Herein, we comprehensively explored the prognostic value and biological function of RNF2 in HCC and revealed its association with histone modification, which would provide a new biomarker for HCC diagnosis and a novel target for HCC treatment. This evidence concerns the gene RNF2 and hepatocellular carcinoma.